Biblio Discovery — Demo Discovery Service

43 hasil untuk "David Leppert"

Menampilkan 1–20 · 1,18 detik · RSS

  1. Artikel Jurnal

    Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis

    Ngoc Dung Le; Lukas Muri; Denis Grandgirard dkk.

    Journal of Neuroinflammation, Vol. 17 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Pneumococcal meningitis (PM) remains a global public health concern and affects all age groups. If acquired during infancy or childhood, permanent neurofunctional deficits including cognitive impairment, cerebral palsy, and secondary epilepsy are typical sequelae of neuronal…

  2. Artikel Jurnal

    Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters

    Marco Hermesdorf; David Leppert; Aleksandra Maceski dkk.

    Scientific Reports, Vol. 12 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Neurofilament light is a constituent of the neuronal cytoskeleton and released into the blood following neuro-axonal damage. It has previously been reported that NfL measured in blood serum is inversely related to body mass index. However, no reports exist with regard to body composition…

  3. Artikel Jurnal

    The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis

    Ngoc Dung Le; Marel Steinfort; Denis Grandgirard dkk.

    Scientific Reports, Vol. 12 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract One-third of pneumococcal meningitis (PM) survivors suffer from neurological sequelae including learning disabilities and hearing loss due to excessive neuroinflammation. There is a lack of efficacious compounds for adjuvant therapy to control this long-term consequence of PM. One hallmark…

  4. Artikel Jurnal

    Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain

    Tanja Sjöros; Maija Saraste; Markus Matilainen dkk.

    Therapeutic Advances in Neurological Disorders, Vol. 18 · 2025 · Inggris · DOAJ Scopus

    Background: Serum glial fibrillary acidic protein (sGFAP) is a promising biomarker for multiple sclerosis (MS) disease progression. Elevated sGFAP levels are considered to reflect ongoing astrocyte-related pathology in the central nervous system. Objectives: To study whether sGFAP levels associate…

  5. Artikel Jurnal

    Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a analysis

    Jens Kuhle; David Leppert; Giancarlo Comi dkk.

    Therapeutic Advances in Neurological Disorders, Vol. 17 · 2024 · Inggris · DOAJ Scopus

    Background: In REFLEX, subcutaneous interferon beta-1a (sc IFN β-1a) delayed the onset of multiple sclerosis (MS) in patients with a first clinical demyelinating event (FCDE). Objectives: This post hoc analysis aimed to determine whether baseline serum neurofilament light (sNfL) chain can predict…

  6. Artikel Jurnal

    Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study

    Nicole Rübsamen; Aleksandra Maceski; David Leppert dkk.

    BMC Medicine, Vol. 19 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Neurofilament light chain (NfL) is a cytoskeletal protein component whose release into blood is indicative of neuronal damage. Tau is a microtubule-associated protein in neurons and strongly associated with overall brain degeneration. NfL and tau levels are associated with…

  7. Artikel Jurnal

    Blood neurofilament light as a potential endpoint in Phase 2 studies in MS

    Maria Pia Sormani; Dieter A. Haering; Harald Kropshofer dkk.

    Annals of Clinical and Translational Neurology, Vol. 6 No. 6 · 2019 · Inggris · DOAJ Scopus

    Abstract Objectives To assess whether neurofilament light chain (NfL) could serve as an informative endpoint in Phase 2 studies in patients with relapsing–remitting multiple sclerosis (RRMS) and estimate the sample size requirements with NfL as the primary endpoint. Methods Using data from the…

  8. Artikel Jurnal

    A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies

    Nicole Rübsamen; Eline A. J. Willemse; David Leppert dkk.

    Frontiers in Neurology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    IntroductionNeurofilament light (NfL) can be detected in blood of healthy individuals and at elevated levels in those with different neurological diseases. We investigated if the choice of biological matrix can affect results when using NfL as biomarker in epidemiological studies.MethodWe obtained…

  9. Artikel Jurnal

    Development of an age‐adjusted model for blood neurofilament light chain

    Christopher Harp; Gian‐Andrea Thanei; Xiaoming Jia dkk.

    Annals of Clinical and Translational Neurology, Vol. 9 No. 4 · 2022 · Inggris · DOAJ Scopus

    Abstract Objective To develop an age‐adjustment model for neurofilament light chain (NfL), an emerging injury marker in patients with a range of neurologic conditions including multiple sclerosis (MS). Methods Serum and plasma samples were collected from a healthy donor (HD) cohort of 118…

  10. Artikel Jurnal

    Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis

    Kamila Zondra Revendova; Chiara Starvaggi Cucuzza; Ali Manouchehrinia dkk.

    Brain and Behavior, Vol. 13 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Neurofilament light (NfL) levels reflect inflammatory disease activity in multiple sclerosis (MS), but it is less clear if NfL also can serve as a biomarker for MS progression in treated patients without relapses and focal lesion accrual. In addition, it has not been well…

  11. Artikel Jurnal

    Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome

    Peter Körtvelyessy; Jens Kuhle; Emrah Düzel dkk.

    Annals of Clinical and Translational Neurology, Vol. 7 No. 11 · 2020 · Inggris · DOAJ Scopus

    Abstract Objective Neurofilament light chain (NfL) has been established as a biomarker of axonal damage in many diseases of the central nervous system (CNS). Increased levels of serum NfL (sNfL) can derive as well from damage in the peripheral nervous system (PNS) as from CNS, but little is known…

  12. Artikel Jurnal

    Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration

    Julia Baguña Torres; Jay Roodselaar; Megan Sealey dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Approval of B-cell-depleting therapies signifies an important advance in the treatment of multiple sclerosis (MS). However, it is unclear whether the administration route of anti-CD20 monoclonal antibodies (mAbs) alters tissue distribution patterns and subsequent downstream effects. This study…

  13. Artikel Jurnal Teks lengkap

    Serum neurofilament light levels in normal aging and their association with morphologic brain changes

    Michael Khalil; Lukas Pirpamer; Edith Hofer dkk.

    Nature Communications · 2020 · Inggris · OpenAlex Scopus

    Neurofilament light (NfL) protein is a marker of neuro-axonal damage and can be measured not only in cerebrospinal fluid but also in serum, which allows for repeated assessments. There is still limited knowledge regarding the association of serum NfL (sNfL) with age and subclinical morphologic…

    Juga tersedia di: DOAJ

  14. Artikel Jurnal

    Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trial

    Leo H Bonati; Urs Fischer; Raphael Guzman dkk.

    BMJ Open, Vol. 16 No. 6 · 2026 · Inggris · DOAJ Scopus

    Background Whether surgical haematoma evacuation leads to reduced brain damage in patients with spontaneous supratentorial intracerebral haemorrhage (SSICH) remains unknown. Blood biomarkers reflecting brain damage could aid in prognosticating the clinical outcome and hence support quantifying the…

  15. Artikel Jurnal

    Neurofilaments: neurobiological foundations for biomarker applications

    Arie Gafson; Nicolas R. Barthélemy; Pascale Bomont dkk.

    Brain · 2020 · Inggris · OpenAlex Scopus

    Interest in neurofilaments has risen sharply in recent years with recognition of their potential as biomarkers of brain injury or neurodegeneration in CSF and blood. This is in the context of a growing appreciation for the complexity of the neurobiology of neurofilaments, new recognition of…

  16. Artikel Jurnal

    Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model

    Tianrong Yeo; Halwan Bayuangga; Marcus Augusto-Oliveira dkk.

    Journal of Neuroinflammation, Vol. 19 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background Despite widespread searches, there are currently no validated biofluid markers for the detection of subclinical neuroinflammation in multiple sclerosis (MS). The dynamic nature of human metabolism in response to changes in homeostasis, as measured by metabolomics, may allow…

  17. Artikel Jurnal

    Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum

    Marisol Herrera-Rivero; Edith Hofer; Aleksandra Maceski dkk.

    Frontiers in Neurology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    IntroductionThe measurement of neurofilament light chain (NfL) in blood is a promising biomarker of neurological injury and disease. We investigated the genetic factors that underlie serum NfL levels (sNfL) of individuals without neurological conditions.MethodsWe performed a discovery genome-wide…

  18. Artikel Jurnal

    Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response

    Cédric Hirzel; Denis Grandgirard; Bernard Surial dkk.

    Therapeutic Advances in Neurological Disorders, Vol. 15 · 2022 · Inggris · DOAJ Scopus

    Background: In coronavirus disease-2019 (COVID-19) patients, there is increasing evidence of neuronal injury by the means of elevated serum neurofilament light chain (sNfL) levels. However, the role of systemic inflammation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific…

  19. Artikel Jurnal

    Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis

    Mattia Rosso; Cindy T. Gonzalez; Brian C. Healy dkk.

    Annals of Clinical and Translational Neurology, Vol. 7 No. 6 · 2020 · Inggris · DOAJ Scopus

    Abstract Objective Multiple sclerosis (MS) is an autoimmune demyelinating disorder, which is characterized by relapses and remissions. Serum neurofilament light chain (sNfL) is an emerging biomarker of disease activity but its clinical use is still limited. In this study, we aim to characterize the…